Research ArticleArticle
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
Konstantinos Tselios, Dafna D. Gladman, Paula Harvey, Shadi Akhtari, Jiandong Su and Murray B. Urowitz
The Journal of Rheumatology August 2018, jrheum.171436; DOI: https://doi.org/10.3899/jrheum.171436
Konstantinos Tselios
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Dafna D. Gladman
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Paula Harvey
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Shadi Akhtari
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Jiandong Su
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Murray B. Urowitz
From the Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; Cardiology Department, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by the University Health Network, Lou and Marissa Rocca, and the Lupus Foundation of Ontario. Dr. Tselios is financially supported by Lupus Ontario. The sponsors had no role in study design or collection and interpretation of the data, or drafting the report. K. Tselios, MD, PhD, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; D.D. Gladman, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; P. Harvey, BMBS, PhD, FRACP, Cardiology Department, Women’s College Hospital, University of Toronto; S. Akhtari, MD, FRCPC, Cardiology Department, Women’s College Hospital, University of Toronto; J. Su, MB, BSc, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network; M.B. Urowitz, MD, FRCPC, Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, University Health Network. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca Accepted for publication June 11, 2018.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
Konstantinos Tselios, Dafna D. Gladman, Paula Harvey, Shadi Akhtari, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Aug 2018, jrheum.171436; DOI: 10.3899/jrheum.171436
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
Konstantinos Tselios, Dafna D. Gladman, Paula Harvey, Shadi Akhtari, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Aug 2018, jrheum.171436; DOI: 10.3899/jrheum.171436